The pleotropic effects of fluvastatin on complement-mediated T-cell activation in hypercholesterolemia-Reference-Cited by-同舟云学术

The pleotropic effects of fluvastatin on complement-mediated T-cell activation in hypercholesterolemia

Published:2021-11 Issue: Volume:143 Page:112224
ISSN:0753-3322
Container-title:Biomedicine & Pharmacotherapy
language:en
Short-container-title:Biomedicine & Pharmacotherapy

Author:

Nyambuya Tawanda Maurice,Dludla Phiwayinkosi Vusi,Mxinwa Vuyolwethu,Nkambule Bongani Brian

Funder

Inyuvesi Yakwazulu-Natali

National Institutes of Health

National Research Foundation

South African Medical Research Council

Publisher

Elsevier BV

Subject

Pharmacology,General Medicine

Reference47 articles.

1. Inflammatory biomarkers in type 2 diabetic patients: effect of glycemic control and impact of ldl subfraction phenotype;Vinagre;Cardiovasc. Diabetol.,2014

2. Risk factors and cardiovascular disease prevention the role of inflammation in diabetes: current concepts and future;Tsalamandris;Perspectives,2019

3. Immunity and inflammation in atherosclerosis;Wolf;Circ. Res.,2019

4. Hypercholesterolemia is associated with a T helper (Th) 1/Th2 switch of the autoimmune response in atherosclerotic apo E-knockout mice;Zhou;J. Clin. Invest.,1998

5. The IL-17A/IL-17RA axis plays a pro-atherogenic role via the regulation of aortic myeloid cell recruitment;Butcher;Circ. Res.,2012

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring the hub mechanisms of ischemic stroke based on protein-protein interaction networks related to ischemic stroke and inflammatory bowel disease;Scientific Reports;2023-01-31

2. Impact of dyslipidemia in the development of cardiovascular complications: Delineating the potential therapeutic role of coenzyme Q10;Biochimie;2023-01

3. Expression of Caspase-3 in Circulating Innate Lymphoid Cells Subtypes Is Altered by Treatment with Metformin and Fluvastatin in High-Fat Diet Fed C57BL/6 Mice;Cells;2022-04-23

4. Activated monocytes as a therapeutic target to attenuate vascular inflammation and lower cardiovascular disease-risk in patients with type 2 diabetes: A systematic review of preclinical and clinical studies;Biomedicine & Pharmacotherapy;2022-02